Cargando…

Epidermal growth factor receptor inhibitor in advanced basal cell carcinoma

Cetuximab can be used for the treatment of advanced basal cell carcinoma, especially when the patient cannot tolerate routine chemotherapy. Future studies are needed to confirm it.

Detalles Bibliográficos
Autores principales:	Amirabadi, Amir, Alami, Amirhosein, Ahanchian, Hamid, Ariaee, Nazila, Moazzen, Nasrin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Case Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8142310/ https://www.ncbi.nlm.nih.gov/pubmed/34084482 http://dx.doi.org/10.1002/ccr3.4021

Ejemplares similares

Inflammatory Myofibroblastic Tumor of Salpinx: a Very Rare Case Treated with a Less Aggressive Method
por: Homaei-Shandiz, Fatemeh, et al.
Publicado: (2014)

Report of Common Aeroallergens among Allergic Patients in Northeastern Iran
por: Mahboubi Oskouei, Yaghoub, et al.
Publicado: (2017)

Investigation of the relationship between atopy and psoriasis
por: Hosseini, Pegah, et al.
Publicado: (2019)

Prevalence of IgE-Mediated Food Hypersensitivity to Cereals and Beans Based on Skin Prick Test in Children with Celiac Disease
por: Jafari, Ali, et al.
Publicado: (2021)

Human Epidermal Growth Factor Receptor 2-Subtype Invasive Ductal Carcinoma Recurring as Basal-Human Epidermal Growth Factor Receptor 2-Subtype Squamous Cell Carcinoma
por: An, Jeongshin, et al.
Publicado: (2019)

COVID‐19 in a child with primary antibody deficiency
por: Ahanchian, Hamid, et al.
Publicado: (2020)

A significant decrease in the gene expression of interleukin-17 following the administration of synbiotic in patients with allergic rhinitis who underwent immunotherapy: A placebo-controlled clinical trial
por: Dehnavi, Sajad, et al.
Publicado: (2019)

A case of epidermal growth factor receptor tyrosine kinase inhibitor effectiveness in epidermal growth factor receptor mutation-positive squamous cell carcinoma
por: Matsumura, Sosuke, et al.
Publicado: (2023)

Epidermal growth factor receptor tyrosine kinase inhibitors
por: Ranson, M
Publicado: (2004)

Targeting the Cardiotoxicity of Epidermal Growth Factor Receptor Inhibitors
por: Uprety, Dipesh, et al.
Publicado: (2020)

Advances in targeting acquired resistance mechanisms to epidermal growth factor receptor tyrosine kinase inhibitors
por: Chen, Justin A., et al.
Publicado: (2020)

The Role of Epidermal Growth Factor Receptor Mutations and Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in the Treatment of Lung Cancer
por: Chang, Shih-Chieh, et al.
Publicado: (2011)

Dermatologic Toxicities in Epidermal Growth Factor Receptor and Multikinase Inhibitors
por: Eaby-Sandy, Beth, et al.
Publicado: (2012)

Epidermal growth factor receptor inhibitors related trichomegaly of Eyelashes
por: Maka, Vinayak V., et al.
Publicado: (2014)

Sensitivities to various epidermal growth factor receptor‐tyrosine kinase inhibitors of uncommon epidermal growth factor receptor mutations L861Q and S768I: What is the optimal epidermal growth factor receptor‐tyrosine kinase inhibitor?
por: Banno, Eri, et al.
Publicado: (2016)

Inhibition of basal-like breast cancer growth by FTY720 in combination with epidermal growth factor receptor kinase blockade
por: Martin, Janet L., et al.
Publicado: (2017)

Prevalence of transient hyperglycemia and diabetes mellitus in pediatric patients with acute leukemia
por: Banihashem, A, et al.
Publicado: (2014)

Expression of transforming growth factor alpha, epidermal growth factor receptor and epidermal growth factor in precursor lesions to gastric carcinoma.
por: Filipe, M. I., et al.
Publicado: (1995)

Epidermal growth factor receptor inhibitor therapy for recurrent respiratory papillomatosis
por: Moldan, Matthew M., et al.
Publicado: (2013)

Cutaneous adverse reactions specific to epidermal growth factor receptor inhibitors
por: Lupu, I, et al.
Publicado: (2015)

Heart Failure Associated With the Epidermal Growth Factor Receptor Inhibitor Osimertinib
por: Piper-Vallillo, Andrew J., et al.
Publicado: (2020)

Epidermal growth factor receptor inhibitor with fluorouracil, leucovorin, and irinotecan as an alternative treatment for advanced upper tract urothelial carcinoma: a case report
por: Lu, Yen-Man, et al.
Publicado: (2016)

Anti‐epidermal growth factor receptor therapy concurrently with induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma
por: Peng, Hao, et al.
Publicado: (2018)

Subsequent treatment of epidermal growth factor receptor-tyrosine kinase inhibitor failure in patients with advanced lung adenocarcinoma
por: Qiao, Xiaojuan, et al.
Publicado: (2015)

The Efficacy and Safety of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Combined With Thymosin in Advanced Non-Small Cell Lung Cancer Patients Harboring Active Epidermal Growth Factor Receptor Mutations
por: Feng, Yongdong, et al.
Publicado: (2021)

Preclinical antitumor activity of S-222611, an oral reversible tyrosine kinase inhibitor of epidermal growth factor receptor and human epidermal growth factor receptor 2
por: Tanaka, Hidekazu, et al.
Publicado: (2014)

Comparison of epidermal growth factor receptor tyrosine kinase inhibitors for patients with lung adenocarcinoma harboring different epidermal growth factor receptor mutation types
por: Park, Sojung, et al.
Publicado: (2021)

A Randomized Controlled Trial of Epidermal Growth Factor Ointment for Treating Epidermal Growth Factor Receptor Inhibitor‐Induced Skin Toxicities
por: Kim, Young Saing, et al.
Publicado: (2019)

Amelioration of patients with chronic spontaneous urticaria in treatment with vitamin D supplement
por: Ariaee, Nazila, et al.
Publicado: (2017)

Balancing Safety and Efficacy of Epidermal Growth Factor Receptor Inhibitors in Patients With Squamous Cell Carcinoma of the Head and Neck
por: Iberri, David J., et al.
Publicado: (2016)

Transformation From Adenocarcinoma to Pleomorphic Carcinoma as an Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors
por: Nishimatsu, Kanako, et al.
Publicado: (2021)

Immunohistochemical detection of epidermal growth factor receptors on human colonic carcinomas.
por: Steele, R. J., et al.
Publicado: (1990)

Epidermal growth factor receptor expression in canine transitional cell carcinoma
por: HANAZONO, Kiwamu, et al.
Publicado: (2014)

The immunoexpression of epidermal growth factor receptor in cutaneous squamous cell carcinoma
por: Nichita, Mirela Marcela, et al.
Publicado: (2021)

Gefitinib (‘Iressa’, ZD1839) and new epidermal growth factor receptor inhibitors
por: Blackledge, G, et al.
Publicado: (2004)

Molecular Determinants of Glioblastoma Response to Epidermal Growth Factor Receptor Kinase Inhibitors
por: Komotar, Ricardo J., et al.
Publicado: (2008)

Clinical activities of the epidermal growth factor receptor family inhibitors in breast cancer
por: Henson, Elizabeth S, et al.
Publicado: (2007)

Dermatological Side Effects of Epidermal Growth Factor Receptor Inhibitors: ‘PRIDE’ Complex
por: Madke, Bhushan, et al.
Publicado: (2014)

Successful treatment of epidermal growth factor receptor inhibitor–induced alopecia with doxycycline
por: Chen, Chen (Amy), et al.
Publicado: (2015)

The incidence and management of cutaneous adverse events of the epidermal growth factor receptor inhibitors
por: Owczarek, Witold, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_f8hoauaef607sjpdtnb7j2dd55